CNSX:PULL

Mind Cure Health Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive PULL News and Ratings via Email

Sign-up to receive the latest news and ratings for Mind Cure Health and its competitors with MarketBeat's FREE daily newsletter.


About Mind Cure Health

Pure Extracts Technologies Corp. operates as a cannabis and hemp extraction company in British Columbia. It is involved in the production of cannabis, cannabidiol (CBD) oil, hemp, and functional mushrooms extracts. The company also offers various derivative cannabis products, including edible products, such as delta-9-tetrahydrocannabinol infused gummies. It has a collaboration with Dr. Alexander MacGregor to develop CBD infused mushroom wellness products, as well as to research optimum extraction methodologies for psilocybin. The company was formerly known as Big Sky Petroleum Corporation and change its name to Pure Extracts Technologies Corp. in October 2020. Pure Extracts Technologies Corp. was incorporated in 2006 and is headquartered in Pemberton, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.70 out of 5 stars

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Mind Cure Health (CNSX:PULL) Frequently Asked Questions

Is Mind Cure Health a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Mind Cure Health in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Mind Cure Health stock.
View analyst ratings for Mind Cure Health
or view top-rated stocks.

What stocks does MarketBeat like better than Mind Cure Health?

Wall Street analysts have given Mind Cure Health a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Mind Cure Health wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for PULL?

1 brokers have issued 12-month price targets for Mind Cure Health's shares. Their forecasts range from $0.90 to $0.90. On average, they anticipate Mind Cure Health's share price to reach $0.90 in the next year.
View analysts' price targets for Mind Cure Health
or view top-rated stocks among Wall Street analysts.

Who are Mind Cure Health's key executives?

Mind Cure Health's management team includes the following people:
  • Mr. Ben Nikolaevsky, CEO & Director
  • Mr. Doug Benville, Founder, COO & Director
  • Ms. Yana Popova CPA, CFO, Corp. Sec. & Director (Age 38)
  • Mr. Andy Gauvin, VP of Sales
  • Mr. Alexander Logie, VP of Bus. Devel.

Who are some of Mind Cure Health's key competitors?

What is Mind Cure Health's stock symbol?

Mind Cure Health trades on the CNSX under the ticker symbol "PULL."

How do I buy shares of Mind Cure Health?

Shares of PULL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Mind Cure Health's official website?

The official website for Mind Cure Health is www.pureextractscorp.com.

How can I contact Mind Cure Health?

The company can be reached via phone at 604 343 2724.


This page was last updated on 7/29/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.